Happy New Year 2018 from IE!

At the start of any New Year, we often see many articles and blogs being published speculating the trends in healthcare launches for the upcoming year. This year is no exception with many talking about hot topics such as the growth of biosimilars and specialty disease markets. With a keen interest in innovative therapies and fresh approaches to the market, IE look to the future of healthcare with optimism and motivation.

However, our primary focus at IE will always be helping pharma companies get the basis of every launch right, on their journey towards launch excellence. Even though every launch is unique, the same core elements carry through for launching any generic, specialty or new indication and therefore it is important to get these right to have launch confidence in 2018, and beyond. Whether your launch is part of a current ‘trend’ in the market or not, any new drug or device brings vital value to those patients who will access it in the future, so it is easy to see why it is so important to get every launch right ensuring your launch is delivered at the right time, in the right place, to the right people.

But how do you ensure launch is successful?

Are there key steps or ingredients others have used with proven success?

How can these be blended into what you are doing?

These are some of the questions we are often asked and for which there are hours of discussion to be had! However, over the years we’ve tried to distil these hours into a few sentences and they all come back to some foundational pillars;

The start of a New Year is the perfect opportunity to reflect on how these foundational pillars underpin your launch planning activities; where are your launch capabilities now and where do you want them to be going forward?

In 2017 IE launched LEx Catalyst, which focusses on getting these key elements of launch right by assessing and enhancing launch capabilities across the 3 areas of; Plan, Platform and People.

The launch of LEx Catalyst stemmed from many of our discussions with clients and connections in pharma about their frustrations in not knowing where or how to start with enhancing their launch capabilities. If you are relating to these frustrations in your organisation, our team are keen to explore them with you to understand your needs. Through the LEx Catalyst process we deliver a tailored report of your current launch capabilities’ situation along with recommendations from our experts on how to enhance any identified gaps. LEx Catalyst can be utilised to assess launch capabilities on a local, regional or global level.

Benefits our LEx Catalyst clients have seen include: 

For more details on LEx Catalyst, see our website or read our brochure.

Make 2018 the year that you achieve your launch ambition; Get in touch to start your LEx Catalyst assessment today!

2018 is set to be an exciting year for IE too; building on our growth of 2017 through launching new services and bringing on board new experts to our team. Throughout 2018, IE aim to advance our vision further, by continuing to bring value to our relationships with current and new clients.

We hope you enjoy hearing about IE’s latest news, and learning about how our services can support your journey towards launch excellence.

To receive details about IE service updates via email join our mailing list.